Cross-Talk Between Notch and EGFR Signaling in Human Breast Cancer Cells

REFERENCES

• Reedijk M., Pinnaduwage D., Dickson B. C., Mulligan A. M., Zhang H., Bull S. B., O'Malley F. P., Egan S. E., Andrulis I. L. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Res Treat 2007, DOI 10.1007/s10549-007-9805-3
   PubMedGoogle Scholar
• Reedijk M., Odorcic S., Chang L., Zhang H., Miller N., McCready D. R., Lockwood G., Egan S. E. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005; 65(18)8530–8537
   PubMed Web of Science ®Google Scholar
• Li J. L., Harris A. L. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell 2005; 8(1)1–3
   PubMed Web of Science ®Google Scholar
• Clark P. A., Treisman D. M., Ebben J., Kuom J. S. Developmental signaling pathways in brain tumor-derived stem-like cells. Dev Dyn 2007; 236(12)3297–3308
   PubMed Web of Science ®Google Scholar
• Weng A. P., Aster J. C. Multiple niches for Notch in cancer: context is everything. Curr Opin Genet Dev 2004; 14(1)48–54
   PubMed Web of Science ®Google Scholar
• Bhanot U. K., KÖhntop R., Hasel C., MÖller P. Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis. J Pathol 2008; 214(3)312–319
   PubMed Web of Science ®Google Scholar
• Ehebauer M., Hayward P., Arias A. M. Notch, a universal arbiter of cell fate decisions. Science 2006; 314(5804)1414–1415
   PubMed Web of Science ®Google Scholar
• Shi W., Harris A. L. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials. J Mammary Gland Biol Neoplasia 2006; 11(1)41–52
   PubMed Web of Science ®Google Scholar
• Hurlbut G. D., Kankel M. W., Lake R. J., Artavanis-Tsakonas S. Crossing paths with Notch in the hyper-network. Curr Opin Cell Biol 2007; 19(2)166–175
   PubMed Web of Science ®Google Scholar
• Leong K. G., Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006; 107(6)2223–2233
   PubMed Web of Science ®Google Scholar
• Ramdass B., Maliekal T. T., Lakshmi S., Rehman M., Rema P., Nair P., Mukherjee G., Reddy B. K., Krishna S., Radhakrishna Pillai M. Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression. Gynecol Oncol 2007; 104(2)352–361
   PubMed Web of Science ®Google Scholar
• Katoh M., Katoh M. Notch signaling in gastrointestinal tract. Int J Oncol 2007; 30(1)247–251
   PubMed Web of Science ®Google Scholar
• Takaori K. Current understanding of precursors to pancreatic cancer. J Hepatobiliary Pancreat Surg 2007; 14(3)217–223
   PubMedGoogle Scholar
• Kanamori M., Kawaguchi T., Nigro J. M., Feuerstein B. G., Berger M. S., Miele L., Pieper R. O. Contribution of Notch signaling activation to human glioblastoma multiforme. J Neurosurg 2007; 106(3)417–427
   PubMed Web of Science ®Google Scholar
• Curry C. L., Reed L. L., Broude E., Golde T. E., Miele L., Foreman K. E. Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-κB signaling. Mol Cancer Ther 2007; 6(7)1983–1992
   PubMed Web of Science ®Google Scholar
• Pece S., Serresi M., Santolini E., Capra M., Hulleman E., Galimberti V., Zurrida S., Maisonneuve P., Viale G., Di Fiore P. P. Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis. J Cell Biol 2004; 167(2)215–221
   PubMed Web of Science ®Google Scholar
• Lu Z., Jiang G., Blume-Jensen P., Hunter T. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 2001; 21(12)4016–4031
   PubMed Web of Science ®Google Scholar
• Friedmann B. J., Caplin M., Savic B., Shah T., Lord C. J., Ashworth A., Hartley J. A., Hochhauser D. Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. Mol Cancer Ther 2006; 5(2)209–218
   PubMed Web of Science ®Google Scholar
• Dutta P. R., Maity A. Cellular responses to EGFR inhibitors and their relevance to cancer therapy. Cancer Lett 2007; 254(2)165–177
   PubMed Web of Science ®Google Scholar
• Qi R., An H., Yu Y., Zhang M., Liu S., Xu H., Guo Z., Cheng T., Cao X. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003; 63(23)8323–8329
   PubMed Web of Science ®Google Scholar
• Hu Y., Nguyen T. T., Bui K. C., Demello D. E., Smith J. B. A novel inflammation-induced ubiquitin E3 ligase in alveolar type II cells. Biochem Biophys Res Commun 2005; 333(1)253–263
   PubMed Web of Science ®Google Scholar
• Freeman B. B., Daw N. C., Geyer J. R., Furman W. L., Stewart C. F. Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients. Cancer Invest 2006; 24(3)310–317
   PubMed Web of Science ®Google Scholar
• Farnie G., Clarke R. B. Mammary stem cells and breast cancer—role of Notch signaling. Stem Cell Rev 2007; 3(2)169–175
   PubMed Web of Science ®Google Scholar
• Bailey J. M., Singh P. K., Hollingsworth M. A. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem 2007; 102(4)829–839
   PubMed Web of Science ®Google Scholar
• Imatani A., Callahan R. Identification of a novel Notch4/int-3 RNA species encoding an activated gene product in certain human tumor cell lines. Oncogene 2000; 19(2)223–231
   PubMed Web of Science ®Google Scholar
• Stylianou S., Clarke R. B., Brennan K. Aberrant activation of Notch signaling in human breast cancer. Cancer Res 2006; 66(3)1517–1525
   PubMed Web of Science ®Google Scholar
• Siziopikou K., Jang M. S., Miao H., Miele L. Notch signaling in ductal carcinoma in situ of the breast [abstract]. Proc Am Assoc Cancer Res 2002; 43: 4
   Google Scholar
• Weijzen S., Rizzo P., Braid M., Vaishnav R., Jonkheer S. M., Zlobin A., Osborne B. A., Gottipati S., Aster J. C., Hahn W. C., Rudolf M., Siziopikou K., Kast W. M., Miele L. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat Med 2002; 8(9)979–986
   PubMed Web of Science ®Google Scholar
• Reedijk M., Odorcic S., Chang L., Zhang H., Miller N., McCready D. R., Lockwood G., Egan S. E. High-level coexpression of Jag1 and Notch1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005; 65(18)8530–8537
   PubMed Web of Science ®Google Scholar
• Zang S., Ji Ch., Qu X., Dong X., Ma D., Ye J., Ma R., Dai J., Guo D. A study on Notch signaling in human breast cancer. Neoplasma 2007; 54(4)304–310
   PubMed Web of Science ®Google Scholar
• Dickson B. C., Mulligan A. M., Zhang H., Lockwood G., O'Malley F. P., Egan S. E., Reedijk M. High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Mod Pathol 2007; 20(6)685–693
   PubMed Web of Science ®Google Scholar
• Rizzo P., Miao H., D'Souza G., Osipo C., Yun J., Zhao H., Mascarenhas J., Wyatt D., Antico G., Hao L., Yao K., Rajan P., Hicks C., Siziopikou K., Selvaggi S., Bashir A., Bhandari D., Marchese A., Lendahl U., Qin J. Z., Tonetti D. A., Albain K., Nickoloff B. J., Miele L. Cross-talk between Notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. Cancer Res 2008; 68(13)5226–5235
   PubMed Web of Science ®Google Scholar
• Lee C. W., Raskett C. M., Prudovsky I., Altieri D. C. Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res 2008; 68(13)5273–5281
   PubMed Web of Science ®Google Scholar
• Schiff B. A., McMurphy A. B., Jasser S. A., Younes M. N., Doan D., Yigitbasi O. G., Kim S., Zhou G., Mandal M., Bekele B. N., Holsinger F. C., Sherman S. I., Yeung S. C., El-Naggar A. K., Myers J. N. Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer. Clin Cancer Res 2004; 10(24)8594–8602
   PubMed Web of Science ®Google Scholar
• Doroquez D. B., Rebay I. Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk. Crit Rev Biochem Mol Biol 2006; 41(6)339–385
   PubMed Web of Science ®Google Scholar
• Purow B. W., Sundaresan T. K., Burdick M. J., Kefas B. A., Comeau L. D., Hawkinson M. P., Su Q., Kotliarov Y., Lee J., Zhang W., Fine H. A. Notch-1 regulates transcription of the epidermal growth factor receptor through p53. Carcinogenesis 2008; 29(5)918–925
   PubMed Web of Science ®Google Scholar
• Kolev V., Mandinova A., Guinea-Viniegra J., Hu B., Lefort K., Lambertini C., Neel V., Dummer R., Wagner E. F., Dotto G. P. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 2008; 278(3)1824–1830
   Google Scholar
• Farnie G., Clarke R. B., Spence K., Pinnock N., Brennan K., Anderson N. G., Bundred N. J. Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 2007; 99(8)616–627
   PubMed Web of Science ®Google Scholar
• Wang Z., Zhang Y., Li Y., Banerjee S., Liao J., Sarkar F. H. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. Mol Cancer Ther 2006; 5(3)483–493
   PubMed Web of Science ®Google Scholar